Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ruan Pimenta

11PUBLICATIONS
26CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Dec 30, 2025
Molecular Profile and Clinical Associations of Androgen Receptor Coactivators and Structural Genes in Benign Prostatic Hyperplasia and Metabolic Syndrome.

Feres Camargo Maluf, Karina Serafim da Silva, Giovana Vilas Boas Caetano

|Nov 26, 2025
MiR-10a as a Potential Biomarker and Therapeutic Target in Localized and Metastatic Prostate Cancer.

Tiago José Borelli Bovo, Juliana Alves de Camargo, Ruan Pimenta

|Nov 11, 2025
A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors.

Bruna Taciane da Silva Bortoleti, Sophia Quasem, Stefanie Maurer

|Sep 03, 2025
Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis.

Karina Serafim da Silva, Vanessa Ribeiro Guimarães, Feres Camargo Maluf

|Jul 25, 2024
Phospholipase A2 expression in prostate cancer as a biomarker of good prognosis: A comprehensive study in patients with long follow-up.

Saulo da Cunha Recuero, Nayara I Viana, Sabrina T Reis

|Oct 14, 2023
The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer.

Juliana A Camargo, Nayara I Viana, Ruan Pimenta

Pageof 2

Frequent Collaborators

7 joint publications

Katia Ramos Moreira Leite

4 joint publications

Nayara Izabel Viana

3 joint publications

Juliana Alves de Camargo

3 joint publications

Gabriel Arantes Dos Santos

3 joint publications

Vanessa Ribeiro Guimarães

3 joint publications

Karina Serafim da Silva

2 joint publications

Saulo Recuero

2 joint publications

Sabrina Thalita Dos Reis

2 joint publications

Vitória Ghazarian

2 joint publications

Miguel Srougi

Frequent Collaborators

7 joint publications

Katia Ramos Moreira Leite

4 joint publications

Nayara Izabel Viana

3 joint publications

Juliana Alves de Camargo

3 joint publications

Gabriel Arantes Dos Santos

Top Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on : Sep 08, 2015

11.2K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

3.7K
See more related videos

Top Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on : Sep 08, 2015

11.2K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

3.7K
See more related videos